A Phase IIa Study of TAS-205 for Duchenne Muscular Dystrophy

Clinical trial NCT02752048 · COMPLETED

Trial details

NCT number: NCT02752048
Sponsor: Taiho Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Duchenne Muscular Dystrophy

Start date: 2016-05-01
Primary completion: 2017-05-15
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.